Skip to main content
Mouhammed Habra, MD, Endocrinology, Houston, TX, University of Texas M.D. Anderson Cancer Center

MouhammedAmirHabraMD

Endocrinology Houston, TX

Adrenal Disease, Diabetes, Osteoporosis & Bone Metabolism Medicine, Thyroid

Professor

Dr. Habra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Habra's full profile

Already have an account?

Summary

  • I am an oncologic endocrinologist at MD Anderson Cancer Center.
    My clinical practice focuses on endocrine tumors and endocrine complications in cancer patients with special interest in adrenal and thyroid tumors.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2005
  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Internal Medicine, 1999 - 2002
  • University of Aleppo Faculty of Medicine
    University of Aleppo Faculty of MedicineClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TN State Medical License
    TN State Medical License 2024 - 2026
  • GA State Medical License
    GA State Medical License 2024 - 2025
  • TX State Medical License
    TX State Medical License 2008 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • LA State Medical License
    LA State Medical License 2024 - 2024
  • AZ State Medical License
    AZ State Medical License 2024 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Management of Adrenocortical Carcinoma 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Treating Malignant Pheochromocytoma in 2018 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018

Press Mentions

  • Management of Adrenocortical Carcinoma
    Management of Adrenocortical CarcinomaApril 10th, 2019
  • Lenvatinib Shows Promise for Patients with Radioiodine-Refractory Thyroid Cancer
    Lenvatinib Shows Promise for Patients with Radioiodine-Refractory Thyroid CancerFebruary 12th, 2015
  • A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy After Primary Surgical Resection in Patients with Adrenocortical Carcinoma, "Beyond the Abstract," by Mouhammed Amir Habra, MD
    A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy After Primary Surgical Resection in Patients with Adrenocortical Carcinoma, "Beyond the Abstract," by Mouhammed Amir Habra, MDFebruary 28th, 2013

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations